BackJounce Therapeutics Overview

Jounce Therapeutics Profit Margin

Profitability ratio analysis for JNCE.

Quarterly Profit Margin

62.15%
99.95% YoY

As of Dec 2022

Annual Profit Margin (TTM)

-62.10%
72.43% YoY

Trailing 12 months ending Dec 2022

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading